Correlation Between Eagle Pharmaceuticals and Procaps Group
Can any of the company-specific risk be diversified away by investing in both Eagle Pharmaceuticals and Procaps Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eagle Pharmaceuticals and Procaps Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eagle Pharmaceuticals and Procaps Group SA, you can compare the effects of market volatilities on Eagle Pharmaceuticals and Procaps Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eagle Pharmaceuticals with a short position of Procaps Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eagle Pharmaceuticals and Procaps Group.
Diversification Opportunities for Eagle Pharmaceuticals and Procaps Group
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eagle and Procaps is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Eagle Pharmaceuticals and Procaps Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procaps Group SA and Eagle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eagle Pharmaceuticals are associated (or correlated) with Procaps Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procaps Group SA has no effect on the direction of Eagle Pharmaceuticals i.e., Eagle Pharmaceuticals and Procaps Group go up and down completely randomly.
Pair Corralation between Eagle Pharmaceuticals and Procaps Group
Given the investment horizon of 90 days Eagle Pharmaceuticals is expected to under-perform the Procaps Group. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eagle Pharmaceuticals is 1.55 times less risky than Procaps Group. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Procaps Group SA is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 279.00 in Procaps Group SA on August 24, 2024 and sell it today you would lose (168.00) from holding Procaps Group SA or give up 60.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 72.8% |
| Values | Daily Returns |
Eagle Pharmaceuticals vs. Procaps Group SA
Performance |
| Timeline |
| Eagle Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Procaps Group SA |
Eagle Pharmaceuticals and Procaps Group Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eagle Pharmaceuticals and Procaps Group
The main advantage of trading using opposite Eagle Pharmaceuticals and Procaps Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eagle Pharmaceuticals position performs unexpectedly, Procaps Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procaps Group will offset losses from the drop in Procaps Group's long position.| Eagle Pharmaceuticals vs. ANI Pharmaceuticals | Eagle Pharmaceuticals vs. Phibro Animal Health | Eagle Pharmaceuticals vs. Prestige Brand Holdings | Eagle Pharmaceuticals vs. Collegium Pharmaceutical |
| Procaps Group vs. Phibro Animal Health | Procaps Group vs. Delta 9 Cannabis | Procaps Group vs. City View Green | Procaps Group vs. Benchmark Botanics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |